Review



mouse kat2a gcn5  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Addgene inc mouse kat2a gcn5
    Fig. 7 <t>Kat2a</t> but not Ep300 acts as a coactivator for retinoic acid signaling. a–e RARE-Luciferase activity from NIH3T3 cells treated or not with 1 µM RA for 20 h. a Cells transfected with expression plasmids containing Ep300, Hdac1, or both (n = 4). b Cells transfected with expression plasmids containing human Hdac1 (H1-WT) or Hdac1 mutant (H1-6R) (n = 4). c Cells transfected with expression plasmids containing Rarα, Rarα, and Ep300 or Rarα and Kat2a (n = 3). d Cells transfected with expression plasmids containing Rere, Rere and Ep300 or Rere and Kat2a (n = 3). e Cells treated either with siRNA for Rere, Ep300, or Kat2a (n = 4). In all graphs data represent mean ± s.e.m. NS—not significant, *P < 0.05 and **P < 0.01. Student’s unpaired two-tailed t-test. f, g RARE-LacZ expression in wild-type Ep300+/+ f and Ep300–/– g embryos at E8.75-E9.0 (dorsal views). h, i In situ hybridization showing somites labeled with Uncx4.1 in wild-type Ep300+/+ h and Ep300–/– i embryos at E8.75-E9.0 (dorsal views). For each genotype at least 5–10 embryos were analyzed. Bar = 100 microns
    Mouse Kat2a Gcn5, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+kat2a+gcn5/pm28959017-219-11-17?v=Addgene+inc
    Average 93 stars, based on 7 article reviews
    mouse kat2a gcn5 - by Bioz Stars, 2026-08
    93/100 stars

    Images

    1) Product Images from "The WHHERE coactivator complex is required for retinoic acid-dependent regulation of embryonic symmetry."

    Article Title: The WHHERE coactivator complex is required for retinoic acid-dependent regulation of embryonic symmetry.

    Journal: Nature communications

    doi: 10.1038/s41467-017-00593-6

    Fig. 7 Kat2a but not Ep300 acts as a coactivator for retinoic acid signaling. a–e RARE-Luciferase activity from NIH3T3 cells treated or not with 1 µM RA for 20 h. a Cells transfected with expression plasmids containing Ep300, Hdac1, or both (n = 4). b Cells transfected with expression plasmids containing human Hdac1 (H1-WT) or Hdac1 mutant (H1-6R) (n = 4). c Cells transfected with expression plasmids containing Rarα, Rarα, and Ep300 or Rarα and Kat2a (n = 3). d Cells transfected with expression plasmids containing Rere, Rere and Ep300 or Rere and Kat2a (n = 3). e Cells treated either with siRNA for Rere, Ep300, or Kat2a (n = 4). In all graphs data represent mean ± s.e.m. NS—not significant, *P < 0.05 and **P < 0.01. Student’s unpaired two-tailed t-test. f, g RARE-LacZ expression in wild-type Ep300+/+ f and Ep300–/– g embryos at E8.75-E9.0 (dorsal views). h, i In situ hybridization showing somites labeled with Uncx4.1 in wild-type Ep300+/+ h and Ep300–/– i embryos at E8.75-E9.0 (dorsal views). For each genotype at least 5–10 embryos were analyzed. Bar = 100 microns
    Figure Legend Snippet: Fig. 7 Kat2a but not Ep300 acts as a coactivator for retinoic acid signaling. a–e RARE-Luciferase activity from NIH3T3 cells treated or not with 1 µM RA for 20 h. a Cells transfected with expression plasmids containing Ep300, Hdac1, or both (n = 4). b Cells transfected with expression plasmids containing human Hdac1 (H1-WT) or Hdac1 mutant (H1-6R) (n = 4). c Cells transfected with expression plasmids containing Rarα, Rarα, and Ep300 or Rarα and Kat2a (n = 3). d Cells transfected with expression plasmids containing Rere, Rere and Ep300 or Rere and Kat2a (n = 3). e Cells treated either with siRNA for Rere, Ep300, or Kat2a (n = 4). In all graphs data represent mean ± s.e.m. NS—not significant, *P < 0.05 and **P < 0.01. Student’s unpaired two-tailed t-test. f, g RARE-LacZ expression in wild-type Ep300+/+ f and Ep300–/– g embryos at E8.75-E9.0 (dorsal views). h, i In situ hybridization showing somites labeled with Uncx4.1 in wild-type Ep300+/+ h and Ep300–/– i embryos at E8.75-E9.0 (dorsal views). For each genotype at least 5–10 embryos were analyzed. Bar = 100 microns

    Techniques Used: Luciferase, Activity Assay, Transfection, Expressing, Mutagenesis, Two Tailed Test, In Situ Hybridization, Labeling



    Similar Products

    93
    Proteintech 1 ap mouse monoclonal anti gcn5 proteintech group
    1 Ap Mouse Monoclonal Anti Gcn5 Proteintech Group, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+kat2a+gcn5/pmc11898288__thnov15p3055s1-105-156-160?v=Proteintech
    Average 93 stars, based on 1 article reviews
    1 ap mouse monoclonal anti gcn5 proteintech group - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    93
    Proteintech mouse kat2a gcn5 monoclonal antibody
    Mouse Kat2a Gcn5 Monoclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+kat2a+gcn5/pm39548054-49-0-4?v=Proteintech
    Average 93 stars, based on 1 article reviews
    mouse kat2a gcn5 monoclonal antibody - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    93
    Addgene inc mouse kat2a gcn5
    Fig. 7 <t>Kat2a</t> but not Ep300 acts as a coactivator for retinoic acid signaling. a–e RARE-Luciferase activity from NIH3T3 cells treated or not with 1 µM RA for 20 h. a Cells transfected with expression plasmids containing Ep300, Hdac1, or both (n = 4). b Cells transfected with expression plasmids containing human Hdac1 (H1-WT) or Hdac1 mutant (H1-6R) (n = 4). c Cells transfected with expression plasmids containing Rarα, Rarα, and Ep300 or Rarα and Kat2a (n = 3). d Cells transfected with expression plasmids containing Rere, Rere and Ep300 or Rere and Kat2a (n = 3). e Cells treated either with siRNA for Rere, Ep300, or Kat2a (n = 4). In all graphs data represent mean ± s.e.m. NS—not significant, *P < 0.05 and **P < 0.01. Student’s unpaired two-tailed t-test. f, g RARE-LacZ expression in wild-type Ep300+/+ f and Ep300–/– g embryos at E8.75-E9.0 (dorsal views). h, i In situ hybridization showing somites labeled with Uncx4.1 in wild-type Ep300+/+ h and Ep300–/– i embryos at E8.75-E9.0 (dorsal views). For each genotype at least 5–10 embryos were analyzed. Bar = 100 microns
    Mouse Kat2a Gcn5, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+kat2a+gcn5/pm28959017-219-11-17?v=Addgene+inc
    Average 93 stars, based on 1 article reviews
    mouse kat2a gcn5 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    99
    Danaher Inc mouse monoclonal anti gcn5 kat2a
    Fig. 7 <t>Kat2a</t> but not Ep300 acts as a coactivator for retinoic acid signaling. a–e RARE-Luciferase activity from NIH3T3 cells treated or not with 1 µM RA for 20 h. a Cells transfected with expression plasmids containing Ep300, Hdac1, or both (n = 4). b Cells transfected with expression plasmids containing human Hdac1 (H1-WT) or Hdac1 mutant (H1-6R) (n = 4). c Cells transfected with expression plasmids containing Rarα, Rarα, and Ep300 or Rarα and Kat2a (n = 3). d Cells transfected with expression plasmids containing Rere, Rere and Ep300 or Rere and Kat2a (n = 3). e Cells treated either with siRNA for Rere, Ep300, or Kat2a (n = 4). In all graphs data represent mean ± s.e.m. NS—not significant, *P < 0.05 and **P < 0.01. Student’s unpaired two-tailed t-test. f, g RARE-LacZ expression in wild-type Ep300+/+ f and Ep300–/– g embryos at E8.75-E9.0 (dorsal views). h, i In situ hybridization showing somites labeled with Uncx4.1 in wild-type Ep300+/+ h and Ep300–/– i embryos at E8.75-E9.0 (dorsal views). For each genotype at least 5–10 embryos were analyzed. Bar = 100 microns
    Mouse Monoclonal Anti Gcn5 Kat2a, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+kat2a+gcn5/pm25479088-44-0-19?v=Danaher+Inc
    Average 99 stars, based on 1 article reviews
    mouse monoclonal anti gcn5 kat2a - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology kat2a sirna mouse
    Figure 6. Effect of <t>KAT2A</t> inactivation in KAT2B-/- MEFs. (A) Western blot analysis of nuclear extracts KAT2B wt, KAT2B-/- MEFs with the antibodies indicated and normalized with Lamin B. (B) Western blot analysis of acid extracts of KAT2B wt and KAT2B-/- MEFs, transfected with siRNA for KAT2A or control scramble siRNA, prepared at three different time points (24, 48, 72 hour post-transfection). The antibodies used are indicated. The H3 antibody was used as loading control and for normalization. (C) Flow citometry histograms of KAT2B wt and KAT2B-/- MEFs, transfected with siRNA for KAT2A or control scramble siRNA at three different time points (24, 48, 72 h). Percentage of cells in the different phases of the cell cycle are shown. (D) Gene expression analysis of cell cycle genes of KAT2B wt and KAT2B-/- MEFs, transfected with siRNA for KAT2A or control scramble siRNA; gene expression was analyzed by q-PCR with the appropriate primers and GAPDH was used for normalization.
    Kat2a Sirna Mouse, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+kat2a+gcn5/pm20505338-164-1-7?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 1 article reviews
    kat2a sirna mouse - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 7 Kat2a but not Ep300 acts as a coactivator for retinoic acid signaling. a–e RARE-Luciferase activity from NIH3T3 cells treated or not with 1 µM RA for 20 h. a Cells transfected with expression plasmids containing Ep300, Hdac1, or both (n = 4). b Cells transfected with expression plasmids containing human Hdac1 (H1-WT) or Hdac1 mutant (H1-6R) (n = 4). c Cells transfected with expression plasmids containing Rarα, Rarα, and Ep300 or Rarα and Kat2a (n = 3). d Cells transfected with expression plasmids containing Rere, Rere and Ep300 or Rere and Kat2a (n = 3). e Cells treated either with siRNA for Rere, Ep300, or Kat2a (n = 4). In all graphs data represent mean ± s.e.m. NS—not significant, *P < 0.05 and **P < 0.01. Student’s unpaired two-tailed t-test. f, g RARE-LacZ expression in wild-type Ep300+/+ f and Ep300–/– g embryos at E8.75-E9.0 (dorsal views). h, i In situ hybridization showing somites labeled with Uncx4.1 in wild-type Ep300+/+ h and Ep300–/– i embryos at E8.75-E9.0 (dorsal views). For each genotype at least 5–10 embryos were analyzed. Bar = 100 microns

    Journal: Nature communications

    Article Title: The WHHERE coactivator complex is required for retinoic acid-dependent regulation of embryonic symmetry.

    doi: 10.1038/s41467-017-00593-6

    Figure Lengend Snippet: Fig. 7 Kat2a but not Ep300 acts as a coactivator for retinoic acid signaling. a–e RARE-Luciferase activity from NIH3T3 cells treated or not with 1 µM RA for 20 h. a Cells transfected with expression plasmids containing Ep300, Hdac1, or both (n = 4). b Cells transfected with expression plasmids containing human Hdac1 (H1-WT) or Hdac1 mutant (H1-6R) (n = 4). c Cells transfected with expression plasmids containing Rarα, Rarα, and Ep300 or Rarα and Kat2a (n = 3). d Cells transfected with expression plasmids containing Rere, Rere and Ep300 or Rere and Kat2a (n = 3). e Cells treated either with siRNA for Rere, Ep300, or Kat2a (n = 4). In all graphs data represent mean ± s.e.m. NS—not significant, *P < 0.05 and **P < 0.01. Student’s unpaired two-tailed t-test. f, g RARE-LacZ expression in wild-type Ep300+/+ f and Ep300–/– g embryos at E8.75-E9.0 (dorsal views). h, i In situ hybridization showing somites labeled with Uncx4.1 in wild-type Ep300+/+ h and Ep300–/– i embryos at E8.75-E9.0 (dorsal views). For each genotype at least 5–10 embryos were analyzed. Bar = 100 microns

    Article Snippet: Human Ep300 in pCMVb was a gift from Richard Eckner and mouse Kat2a (Gcn5) in pCMV-sport247 (Invitrogen) (Addgene plasmid 23098) was a gift from Sharon Dent.

    Techniques: Luciferase, Activity Assay, Transfection, Expressing, Mutagenesis, Two Tailed Test, In Situ Hybridization, Labeling

    Figure 6. Effect of KAT2A inactivation in KAT2B-/- MEFs. (A) Western blot analysis of nuclear extracts KAT2B wt, KAT2B-/- MEFs with the antibodies indicated and normalized with Lamin B. (B) Western blot analysis of acid extracts of KAT2B wt and KAT2B-/- MEFs, transfected with siRNA for KAT2A or control scramble siRNA, prepared at three different time points (24, 48, 72 hour post-transfection). The antibodies used are indicated. The H3 antibody was used as loading control and for normalization. (C) Flow citometry histograms of KAT2B wt and KAT2B-/- MEFs, transfected with siRNA for KAT2A or control scramble siRNA at three different time points (24, 48, 72 h). Percentage of cells in the different phases of the cell cycle are shown. (D) Gene expression analysis of cell cycle genes of KAT2B wt and KAT2B-/- MEFs, transfected with siRNA for KAT2A or control scramble siRNA; gene expression was analyzed by q-PCR with the appropriate primers and GAPDH was used for normalization.

    Journal: Cell cycle (Georgetown, Tex.)

    Article Title: Single nucleosome ChIPs identify an extensive switch of acetyl marks on cell cycle promoters.

    doi: 10.4161/cc.9.11.11839

    Figure Lengend Snippet: Figure 6. Effect of KAT2A inactivation in KAT2B-/- MEFs. (A) Western blot analysis of nuclear extracts KAT2B wt, KAT2B-/- MEFs with the antibodies indicated and normalized with Lamin B. (B) Western blot analysis of acid extracts of KAT2B wt and KAT2B-/- MEFs, transfected with siRNA for KAT2A or control scramble siRNA, prepared at three different time points (24, 48, 72 hour post-transfection). The antibodies used are indicated. The H3 antibody was used as loading control and for normalization. (C) Flow citometry histograms of KAT2B wt and KAT2B-/- MEFs, transfected with siRNA for KAT2A or control scramble siRNA at three different time points (24, 48, 72 h). Percentage of cells in the different phases of the cell cycle are shown. (D) Gene expression analysis of cell cycle genes of KAT2B wt and KAT2B-/- MEFs, transfected with siRNA for KAT2A or control scramble siRNA; gene expression was analyzed by q-PCR with the appropriate primers and GAPDH was used for normalization.

    Article Snippet: The KAT2A siRNA (mouse) was purchased by Santa Cruz Biotechnology (sc-37947).

    Techniques: Western Blot, Transfection, Control, Gene Expression